Inge M van Oort

Inge M van Oort

UNVERIFIED PROFILE

Are you Inge M van Oort?   Register this Author

Register author
Inge M van Oort

Inge M van Oort

Publications by authors named "Inge M van Oort"

Are you Inge M van Oort?   Register this Author

56Publications

1477Reads

24Profile Views

Patient Selection for Radium-223 Therapy in Patients With Bone Metastatic Castration-Resistant Prostate Cancer: New Recommendations and Future Perspectives.

Clin Genitourin Cancer 2019 Apr 22;17(2):79-87. Epub 2018 Nov 22.

Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2018.11.008DOI Listing
April 2019

The Combination of Enzalutamide and Opioids: A Painful Pitfall?

Eur Urol 2019 02 21;75(2):351-352. Epub 2018 Sep 21.

Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838183066
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2018.09.011DOI Listing
February 2019

Difficulties in Pain Management Using Oxycodone and Fentanyl in Enzalutamide-Treated Patients With Advanced Prostate Cancer.

J Pain Symptom Manage 2018 04 22;55(4):e6-e8. Epub 2017 Nov 22.

Department of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2017.11.016DOI Listing
April 2018

Drug-drug interaction potential in men treated with enzalutamide: Mind the gap.

Br J Clin Pharmacol 2018 Jan 18;84(1):122-129. Epub 2017 Oct 18.

Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bcp.13425
Publisher Site
http://dx.doi.org/10.1111/bcp.13425DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736854PMC
January 2018

A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection.

Prostate 2017 Oct 29;77(14):1401-1407. Epub 2017 Aug 29.

Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23401DOI Listing
October 2017

The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisited.

Prostate 2016 07 14;76(10):897-904. Epub 2016 Mar 14.

Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23179DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069637PMC
July 2016

PREDICT: model for prediction of survival in localized prostate cancer.

World J Urol 2016 Jun 29;34(6):789-95. Epub 2015 Sep 29.

Department of Radiation Oncology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-015-1691-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879170PMC
June 2016

Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer.

Clin Cancer Res 2015 Jul 18;21(13):3061-70. Epub 2015 Mar 18.

Radboud University Nijmegen Medical Centre, Department of Urology, Nijmegen, the Netherlands. Noviogendix, Department of Research and Development, Nijmegen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-3334DOI Listing
July 2015

Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review.

Urol Oncol 2015 Jun 17;33(6):265.e1-7. Epub 2014 Sep 17.

Department of Urology, CHU Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université Paris 7 Diderot, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2014.08.007DOI Listing
June 2015

Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey.

BJU Int 2015 Apr 11;115(4):571-9. Epub 2014 Aug 11.

Centre of Uronephrology and Renal Transplantation, Fundeni Clinical Institute, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12796DOI Listing
April 2015

Known susceptibility SNPs for sporadic prostate cancer show a similar association with "hereditary" prostate cancer.

Prostate 2015 Apr 5;75(5):474-83. Epub 2015 Jan 5.

Department for Health Evidence, Radboud university medical center, Nijmegen, The Netherlands; Department of Urology, Radboud university medical center, Nijmegen, The Netherlands; The Netherlands Foundation for the Detection of Hereditary Tumours, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.22933DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680338PMC
April 2015

Self-reported acne is not associated with prostate cancer.

Urol Oncol 2014 Oct 8;32(7):941-5. Epub 2014 Jul 8.

Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands; Comprehensive Cancer Centre The Netherlands, Nijmegen, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2014.02.019DOI Listing
October 2014

Prostate cancer biomarker profiles in urinary sediments and exosomes.

J Urol 2014 Apr 7;191(4):1132-8. Epub 2013 Nov 7.

Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Research and Development, NovioGendix, Nijmegen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2013.11.001DOI Listing
April 2014

Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study.

Invest Radiol 2014 Mar;49(3):165-72

From the Departments of *Radiology, and †Urology, Radboud University Nijmegen Medical Centre; ‡Department of Urology, Canisius Wilhelmina Hospital, Nijmegen; §Department of Urology, Jeroen Bosch Hospital, Den Bosch; ∥Department of Urology, Alysis Zorggroep, Arnhem; ¶Department of Urology, Erasmus University Medical Centre, Rottterdam; and #Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://clinical-mri.com/wp-content/uploads/2014/02/Value_of_
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/RLI.0000000000000008DOI Listing
March 2014

Cabazitaxel in patients with metastatic castration-resistant prostate cancer: results of a compassionate use program in the Netherlands.

Clin Genitourin Cancer 2013 Sep 6;11(3):238-250.e1. Epub 2013 May 6.

Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2013.04.004DOI Listing
September 2013

Value of PCA3 to predict biopsy outcome and its potential role in selecting patients for multiparametric MRI.

Int J Mol Sci 2013 May 28;14(6):11347-55. Epub 2013 May 28.

Department of Urology, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms140611347DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709735PMC
May 2013

Prognostic relevance of number and bilaterality of positive surgical margins after radical prostatectomy.

World J Urol 2012 Feb 15;30(1):105-10. Epub 2011 Jan 15.

Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-010-0641-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264849PMC
February 2012

Prostate brachytherapy and second primary cancer risk: a competitive risk analysis.

J Clin Oncol 2011 Dec 24;29(34):4510-5. Epub 2011 Oct 24.

Department of Radiation Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.35.0991DOI Listing
December 2011

A germline variant in the TP53 polyadenylation signal confers cancer susceptibility.

Authors:
Simon N Stacey Patrick Sulem Aslaug Jonasdottir Gisli Masson Julius Gudmundsson Daniel F Gudbjartsson Olafur T Magnusson Sigurjon A Gudjonsson Bardur Sigurgeirsson Kristin Thorisdottir Rafn Ragnarsson Kristrun R Benediktsdottir Bjørn A Nexø Anne Tjønneland Kim Overvad Peter Rudnai Eugene Gurzau Kvetoslava Koppova Kari Hemminki Cristina Corredera Victoria Fuentelsaz Pilar Grasa Sebastian Navarrete Fernando Fuertes Maria D García-Prats Enrique Sanambrosio Angeles Panadero Ana De Juan Almudena Garcia Fernando Rivera Dolores Planelles Virtudes Soriano Celia Requena Katja K Aben Michelle M van Rossum Ruben G H M Cremers Inge M van Oort Dick-Johan van Spronsen Jack A Schalken Wilbert H M Peters Brian T Helfand Jenny L Donovan Freddie C Hamdy Daniel Badescu Ovidiu Codreanu Mariana Jinga Irma E Csiki Vali Constantinescu Paula Badea Ioan N Mates Daniela E Dinu Adrian Constantin Dana Mates Sjofn Kristjansdottir Bjarni A Agnarsson Eirikur Jonsson Rosa B Barkardottir Gudmundur V Einarsson Fridbjorn Sigurdsson Pall H Moller Tryggvi Stefansson Trausti Valdimarsson Oskar T Johannsson Helgi Sigurdsson Thorvaldur Jonsson Jon G Jonasson Laufey Tryggvadottir Terri Rice Helen M Hansen Yuanyuan Xiao Daniel H Lachance Brian Patrick O Neill Matthew L Kosel Paul A Decker Gudmar Thorleifsson Hrefna Johannsdottir Hafdis T Helgadottir Asgeir Sigurdsson Valgerdur Steinthorsdottir Annika Lindblom Robert S Sandler Temitope O Keku Karina Banasik Torben Jørgensen Daniel R Witte Torben Hansen Oluf Pedersen Viorel Jinga David E Neal William J Catalona Margaret Wrensch John Wiencke Robert B Jenkins Eduardo Nagore Ulla Vogel Lambertus A Kiemeney Rajiv Kumar José I Mayordomo Jon H Olafsson Augustine Kong Unnur Thorsteinsdottir Thorunn Rafnar Kari Stefansson

Nat Genet 2011 Sep 25;43(11):1098-103. Epub 2011 Sep 25.

deCODE genetics, Reykjavik, Iceland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.926DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263694PMC
September 2011

Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer.

Eur J Cancer 2010 Dec 17;46(18):3294-9. Epub 2010 Jun 17.

Department of Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical Centre, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2010.05.020DOI Listing
December 2010

[Multiparametric MRI for prostate cancer screening].

Ned Tijdschr Geneeskd 2009 ;153:B487

Universitair Medisch Centrum St. Radboud, Afd. Radiologie, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
January 2010